Regeneron Pharmaceuticals, Inc. (BVMF:REGN34)

Regeneron Pharmaceuticals Statistics

Total Valuation

BVMF:REGN34 has a market cap or net worth of BRL 420.74 billion. The enterprise value is 340.30 billion.

Market Cap	420.74B
Enterprise Value	340.30B

Important Dates

The last earnings date was Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	Nov 18, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-5.65%
Shares Change (QoQ)	+0.28%
Owned by Insiders (%)	3.79%
Owned by Institutions (%)	87.73%
Float	98.54M

Valuation Ratios

The trailing PE ratio is 16.96 and the forward PE ratio is 16.31.

PE Ratio	16.96
Forward PE	16.31
PS Ratio	5.33
PB Ratio	2.44
P/TBV Ratio	2.55
P/FCF Ratio	18.72
P/OCF Ratio	15.34
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.23, with an EV/FCF ratio of 15.14.

EV / Earnings	13.71
EV / Sales	4.55
EV / EBITDA	15.23
EV / EBIT	17.61
EV / FCF	15.14

Financial Position

The company has a current ratio of 4.13, with a Debt / Equity ratio of 0.11.

Current Ratio	4.13
Quick Ratio	3.28
Debt / Equity	0.11
Debt / EBITDA	0.81
Debt / FCF	0.85
Interest Coverage	84.52

Financial Efficiency

Return on equity (ROE) is 14.87% and return on invested capital (ROIC) is 12.42%.

Return on Equity (ROE)	14.87%
Return on Assets (ROA)	5.91%
Return on Invested Capital (ROIC)	12.42%
Return on Capital Employed (ROCE)	10.23%
Weighted Average Cost of Capital (WACC)	6.16%
Revenue Per Employee	5.13M
Profits Per Employee	1.61M
Employee Count	15,222
Asset Turnover	0.37
Inventory Turnover	2.53

Taxes

In the past 12 months, BVMF:REGN34 has paid 4.00 billion in taxes.

Income Tax	4.00B
Effective Tax Rate	13.88%

Stock Price Statistics

The stock price has increased by +0.73% in the last 52 weeks. The beta is 0.39, so BVMF:REGN34's price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	+0.73%
50-Day Moving Average	67.92
200-Day Moving Average	56.50
Relative Strength Index (RSI)	52.93
Average Volume (20 Days)	1,305

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.37

Income Statement

In the last 12 months, BVMF:REGN34 had revenue of BRL 79.00 billion and earned 24.81 billion in profits. Earnings per share was 228.47.

Revenue	79.00B
Gross Profit	35.21B
Operating Income	20.39B
Pretax Income	28.81B
Net Income	24.81B
EBITDA	23.39B
EBIT	20.39B
Earnings Per Share (EPS)	228.47

Balance Sheet

The company has 47.40 billion in cash and 19.03 billion in debt, with a net cash position of 84.89 billion.

Cash & Cash Equivalents	47.40B
Total Debt	19.03B
Net Cash	84.89B
Net Cash Per Share	n/a
Equity (Book Value)	172.16B
Book Value Per Share	1,678.00
Working Capital	75.20B

Cash Flow

In the last 12 months, operating cash flow was 27.42 billion and capital expenditures -4.95 billion, giving a free cash flow of 22.48 billion.

Operating Cash Flow	27.42B
Capital Expenditures	-4.95B
Free Cash Flow	22.48B
FCF Per Share	n/a

Margins

Gross margin is 44.57%, with operating and profit margins of 25.81% and 31.41%.

Gross Margin	44.57%
Operating Margin	25.81%
Pretax Margin	36.47%
Profit Margin	31.41%
EBITDA Margin	29.60%
EBIT Margin	25.81%
FCF Margin	28.45%

Dividends & Yields

This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 0.32%.

Dividend Per Share	0.22
Dividend Yield	0.32%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	8.22%
Buyback Yield	5.65%
Shareholder Yield	5.97%
Earnings Yield	5.90%
FCF Yield	5.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 28, 2022. It was a forward split with a ratio of 12.

Last Split Date	Nov 28, 2022
Split Type	Forward
Split Ratio	12

Scores

BVMF:REGN34 has an Altman Z-Score of 6.51 and a Piotroski F-Score of 4.

Altman Z-Score	6.51
Piotroski F-Score	4